• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

回旋加速器从电镀镭靶中生产锕。

Cyclotron production of Ac from an electroplated Ra target.

机构信息

Department of Advanced Nuclear Medicine Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-Ku, Chiba, 263-8555, Japan.

Theranostics Research Center, Nihon Medi-Physics, Co., Ltd., Chiba, Japan.

出版信息

Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):279-289. doi: 10.1007/s00259-021-05460-7. Epub 2021 Jul 1.

DOI:10.1007/s00259-021-05460-7
PMID:34196752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8712309/
Abstract

PURPOSE

We demonstrate cyclotron production of high-quality Ac using an electroplated Ra target.

METHODS

Ra was extracted from legacy Ra sources using a chelating resin. Subsequent ion-exchange purification gave pure Ra with a certain amount of carrier Ba. The radium target was prepared by electroplating. We successfully deposited about 37 MBq of Ra on a target box. Maximum activation was achieved using 15.6 MeV protons on the target at 20 µA for 5 h. Two functional resins with various concentrations of nitric acid purified Ac and recovered Ra. Cooling the intermediate Ac for 2-3 weeks decayed the major byproduct of Ac and increased the radionuclidic purity of Ac. Repeating the same separation protocol provided high-quality Ac.

RESULTS

We obtained Ac at a yield of about 2.4 MBq at the end of bombardment (EOB), and the subsequent initial purification gave 1.7 MBq of Ac with Ac/Ac ratio of < 3% at 4 days from EOB. Additional cooling time coupled with the separation procedure (secondary purification) effectively increased the Ac (4n + 1 series) radionuclidic purity up to 99 + %. The recovered Ac had a similar identification to commercially available Ac originating from a Th/Ac generator.

CONCLUSION

This procedure, which involves the Ra(p,2n)Ac reaction and the appropriate purification, has the potential to be a major alternative pathway for Ac production because it can be performed in any facility with a compact cyclotron to address the increasing demand for Ac.

摘要

目的

我们使用电镀的镭靶展示回旋加速器生产高质量的锕。

方法

使用螯合树脂从遗留的镭源中提取镭。随后的离子交换纯化得到了具有一定量载体钡的纯镭。镭靶通过电镀制备。我们成功地在靶盒上沉积了约 37MBq 的镭。使用 15.6MeV 质子在 20µA 下对靶进行 5 小时的最大激活。两种具有不同硝酸浓度的功能树脂对锕进行了纯化并回收了镭。将中间锕冷却 2-3 周可衰减锕的主要副产物并提高锕的放射性核纯度。重复相同的分离方案可提供高质量的锕。

结果

我们在轰击结束时获得了约 2.4MBq 的锕产量,随后的初始纯化在 EOB 后 4 天得到了 1.7MBq 的锕,锕/锕比<3%。额外的冷却时间与分离程序(二次纯化)相结合可有效地将锕(4n+1 系列)的放射性核纯度提高到 99%以上。回收的锕与来自 Th/Ac 发生器的商业可得锕具有相似的特征。

结论

该方法涉及 Ra(p,2n)Ac 反应和适当的纯化,有可能成为锕生产的主要替代途径,因为它可以在任何具有紧凑型回旋加速器的设施中进行,以满足对锕的日益增长的需求。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e98/8712309/6af29256fded/259_2021_5460_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e98/8712309/878eb80d1092/259_2021_5460_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e98/8712309/a69d211e5798/259_2021_5460_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e98/8712309/254423e9dcdd/259_2021_5460_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e98/8712309/bf7ce2a2221e/259_2021_5460_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e98/8712309/a001ebe5fe93/259_2021_5460_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e98/8712309/92e2590a0001/259_2021_5460_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e98/8712309/6af29256fded/259_2021_5460_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e98/8712309/878eb80d1092/259_2021_5460_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e98/8712309/a69d211e5798/259_2021_5460_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e98/8712309/254423e9dcdd/259_2021_5460_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e98/8712309/bf7ce2a2221e/259_2021_5460_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e98/8712309/a001ebe5fe93/259_2021_5460_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e98/8712309/92e2590a0001/259_2021_5460_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e98/8712309/6af29256fded/259_2021_5460_Fig7_HTML.jpg

相似文献

1
Cyclotron production of Ac from an electroplated Ra target.回旋加速器从电镀镭靶中生产锕。
Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):279-289. doi: 10.1007/s00259-021-05460-7. Epub 2021 Jul 1.
2
Cyclotron production of Ac-225 for targeted alpha therapy.用于靶向α治疗的回旋加速器生产Ac-225。
Appl Radiat Isot. 2005 Mar;62(3):383-7. doi: 10.1016/j.apradiso.2004.06.013.
3
Production of high-purity radium-223 from legacy actinium-beryllium neutron sources.从传统锕铍中子源生产高纯度镭-223。
Curr Radiopharm. 2012 Jul;5(3):244-52. doi: 10.2174/1874471011205030244.
4
High-yield cyclotron production of Pb using a sealed Tl solid target.采用密封的 Tl 固体靶从高产量回旋加速器生产 Pb。
Nucl Med Biol. 2023 Jan-Feb;116-117:108314. doi: 10.1016/j.nucmedbio.2023.108314. Epub 2023 Jan 13.
5
Production of Ga-68 with a General Electric PETtrace cyclotron by liquid target.用通用电气 PETtrace 回旋加速器的液体靶生产 Ga-68。
Phys Med. 2018 Nov;55:116-126. doi: 10.1016/j.ejmp.2018.10.018. Epub 2018 Oct 25.
6
Actinium-225 photonuclear production in nuclear reactors using a mixed radium-226 and gadolinium-157 target.使用镭 - 226和钆 - 157混合靶在核反应堆中进行锕 - 225的光核生产。
Nucl Med Biol. 2024 Sep-Oct;136-137:108940. doi: 10.1016/j.nucmedbio.2024.108940. Epub 2024 Jul 4.
7
Selective separation of radium and actinium from bulk thorium target material on strong acid cation exchange resin from sulfate media.在硫酸盐介质中,利用强酸性阳离子交换树脂从大量钍靶材料中选择性分离镭和锕。
Appl Radiat Isot. 2018 Oct;140:18-23. doi: 10.1016/j.apradiso.2018.06.008. Epub 2018 Jun 21.
8
Improved procedures for production and purification of La from enriched [Ba]BaCO on a 16.5 MeV cyclotron.在16.5兆电子伏回旋加速器上从富集的[钡]碳酸钡中生产和纯化镧的改进程序。
Appl Radiat Isot. 2023 Feb;192:110612. doi: 10.1016/j.apradiso.2022.110612. Epub 2022 Dec 8.
9
Production of therapeutic quantities of (64)Cu using a 12 MeV cyclotron.使用12兆电子伏特回旋加速器生产治疗剂量的(64)铜。
Nucl Med Biol. 2003 Jul;30(5):535-9. doi: 10.1016/s0969-8051(03)00024-6.
10
The application of poorly crystalline silicotitanate in production of Ac. poorly 晶硅酸钛在 Ac 生产中的应用。
Sci Rep. 2019 Aug 14;9(1):11808. doi: 10.1038/s41598-019-48021-7.

引用本文的文献

1
Current landscape and future directions of targeted-alpha-therapy for glioblastoma treatment.胶质母细胞瘤治疗中靶向α疗法的现状与未来方向
Theranostics. 2025 Mar 31;15(11):4861-4889. doi: 10.7150/thno.106081. eCollection 2025.
2
Real-time trajectory imaging of alpha particles emitted from actinium-225 and its daughter radionuclides.锕-225及其子放射性核素发射的α粒子的实时轨迹成像
Sci Rep. 2025 Jan 20;15(1):2534. doi: 10.1038/s41598-025-87014-7.
3
Solvent extraction of Ac-225 in nano-layer coated, solvent resistant PDMS microfluidic chips.

本文引用的文献

1
Radiobiologic principles in radionuclide therapy.放射性核素治疗中的放射生物学原理。
J Nucl Med. 2005 Jan;46 Suppl 1:4S-12S.
在纳米层涂层、耐溶剂聚二甲基硅氧烷微流控芯片中对Ac-225进行溶剂萃取。
Sci Rep. 2024 Dec 2;14(1):29988. doi: 10.1038/s41598-024-81177-5.
4
In vivo stable At-labeled prostate-specific membrane antigen-targeted tracer using a neopentyl glycol structure.使用新戊二醇结构的体内稳定镥标记的前列腺特异性膜抗原靶向示踪剂。
EJNMMI Radiopharm Chem. 2024 Jun 17;9(1):48. doi: 10.1186/s41181-024-00278-8.
5
Implementing Ac-225 labelled radiopharmaceuticals: practical considerations and (pre-)clinical perspectives.实施锕-225标记的放射性药物:实际考量与(临床前)临床前景
EJNMMI Radiopharm Chem. 2024 Feb 6;9(1):9. doi: 10.1186/s41181-024-00239-1.
6
Alpha-Emitting Radionuclides: Current Status and Future Perspectives.发射α粒子的放射性核素:现状与未来展望
Pharmaceuticals (Basel). 2024 Jan 8;17(1):76. doi: 10.3390/ph17010076.
7
Comparison of Nuclear Medicine Therapeutics Targeting PSMA among Alpha-Emitting Nuclides.比较 PSMA 靶向 α 发射核素的核医学治疗。
Int J Mol Sci. 2024 Jan 11;25(2):933. doi: 10.3390/ijms25020933.
8
Theranostic Imaging Surrogates for Targeted Alpha Therapy: Progress in Production, Purification, and Applications.靶向α治疗的诊疗一体化成像替代物:生产、纯化及应用进展
Pharmaceuticals (Basel). 2023 Nov 17;16(11):1622. doi: 10.3390/ph16111622.
9
Development of Ac Production from Low Isotopic Dilution Th.低同位素稀释钍的锕生产发展
ACS Omega. 2023 Sep 27;8(42):38822-38827. doi: 10.1021/acsomega.3c01769. eCollection 2023 Oct 24.
10
Alpha Particle-Emitting Radiopharmaceuticals as Cancer Therapy: Biological Basis, Current Status, and Future Outlook for Therapeutics Discovery.《用于癌症治疗的α粒子发射放射性药物:治疗学发现的生物学基础、现状和未来展望》
Mol Imaging Biol. 2023 Dec;25(6):991-1019. doi: 10.1007/s11307-023-01857-y. Epub 2023 Oct 16.